Syndax Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	295.61	74.47	222.08	115.36	24.61	33.87	35.27	24	23.23	10.06
Short-Term Investments	282.19	410.04	224.87	177.82	35.17	47.14	94.81	81.49	63.31	2.2
Cash & Cash Equivalents	577.8	484.51	446.95	293.18	59.78	81.01	130.08	105.48	86.54	12.26
Cash Growth	19.25%	8.41%	52.45%	390.47%	-26.21%	-37.72%	23.32%	21.88%	605.95%	-
Receivables	0	3.47	0	0	0	0	0	0	0	0
Other Current Assets	3.08	1.8	1.45	5.68	2.56	2.33	3.36	3.03	1.46	0.19
Total Current Assets	580.88	489.79	448.4	298.86	62.33	83.35	133.44	108.51	88.01	12.44
Property, Plant & Equipment	1.5	1.06	1.26	0.48	1	0.37	0.27	0.26	0.09	0.03
Long-Term Investments	29.83	5.47	0	0	0	0	3.25	0	0	0
Other Long-Term Assets	0.68	0.92	0	1.27	0.2	0.22	0.23	0.24	1.81	0.34
Total Long-Term Assets	32	7.45	1.26	1.75	1.19	0.59	3.74	0.5	1.9	0.37
Total Assets	612.88	497.24	449.66	300.61	63.53	83.94	137.19	109.01	89.9	12.82
Accounts Payable	17.19	4.35	5.67	3.51	6.18	1.44	2.23	2.38	1.45	0.35
Deferred Revenue	0	0	0	13.13	14.65	16.17	18.33	15.44	16.66	0
Current Debt	1.05	0.44	0.36	2.6	0.48	0	0	0	0	6.45
Other Current Liabilities	39.86	24.28	14.65	-0.37	-2.94	-1.5	-4.77	-7.45	-13.27	3.54
Total Current Liabilities	58.1	29.07	20.68	18.87	18.37	16.11	15.8	10.37	4.85	10.35
Long-Term Debt	0.59	0.72	20.61	17.94	0.42	0	0	0	0	7.44
Other Long-Term Liabilities	0	0	0	11.62	13.14	14.79	17.07	14.51	18.36	0.75
Total Long-Term Liabilities	0.59	0.72	20.61	29.55	13.56	14.79	17.07	14.51	18.36	8.19
Total Liabilities	58.68	29.79	41.29	48.43	31.93	30.89	32.87	24.87	23.21	18.53
Total Debt	1.64	1.16	20.97	20.54	0.9	0	0	0	0	13.88
Debt Growth	40.83%	-94.46%	2.10%	2189.41%	-	-	-	-	-	-
Retained Earnings	-902.4	-693.04	-543.7	-568.63	-495.47	-439.42	-366.11	-305.29	-259.68	-159.8
Comprehensive Income	0.22	-0.81	0.05	-0	0	-0.03	-0.14	0.06	0.03	0
Shareholders' Equity	554.2	467.45	408.37	252.19	31.6	53.05	104.32	84.14	-252.42	-152.57
Net Cash / Debt	576.17	483.35	425.98	272.64	58.88	81.01	130.08	105.48	86.54	-1.63
Net Cash / Debt Growth	19.20%	13.47%	56.24%	363.07%	-27.32%	-37.72%	23.32%	21.88%	-	-
Net Cash Per Share	8.19	7.95	7.94	6.60	1.93	3.19	6.20	7.21	1266.14	-27.93
Working Capital	522.78	460.72	427.71	279.99	43.96	67.24	117.64	98.14	83.16	2.1
Book Value Per Share	7.88	7.69	7.84	6.11	1.04	2.09	4.97	5.75	-3692.87	-2622.32

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).